D.E. Shaw & Co’s SCP & CO Healthcare Acquisition Company Class A Common Stock SHAC Stock Holding History

D.E. Shaw & Co’s Portfolio SHAC Stock Details SHAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-402,144	Closed	-$3.97M	–	5453
2022 Q3	$3.97M	Hold	402,144	–	–	﹤0.01%	2345
2022 Q2	$3.94M	Buy	402,144 +135,644	+51%	+$1.33M	﹤0.01%	2418
2022 Q1	$2.61M	Sell	266,500 -167,072	-39%	-$1.63M	﹤0.01%	3037
2021 Q4	$4.25M	Buy	433,572 +348,705	+411%	+$3.4M	﹤0.01%	2564
2021 Q3	$826K	Buy	+84,867	New	+$821K	﹤0.01%	3757

D.E. Shaw & Co's SHAC Position: Q4 2022 in Review

D.E. Shaw & Co sold out of SCP & CO Healthcare Acquisition Company Class A Common Stock (SHAC) in Q4 2022, closing a stake of 402,144 shares — an estimated $3.97M sold.

D.E. Shaw & Co first reported a position in SHAC in Q3 2021 and held it in 5 quarters. The position peaked at $4.25M in Q4 2021. 0 funds tracked by Wall St. Rank hold SHAC as of Q4 2022.

D.E. Shaw & Co reported no remaining SCP & CO Healthcare Acquisition Company Class A Common Stock position as of Q4 2022 after selling out during the quarter.
D.E. Shaw & Co sold 402,144 SCP & CO Healthcare Acquisition Company Class A Common Stock shares in Q4 2022, an estimated $3.97M.
D.E. Shaw & Co first reported a position in SCP & CO Healthcare Acquisition Company Class A Common Stock in Q3 2021 and held it in 5 quarters.
D.E. Shaw & Co's SCP & CO Healthcare Acquisition Company Class A Common Stock position peaked at $4.25M in Q4 2021.
0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Class A Common Stock as of Q4 2022.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.